News provided by Calibrate Health, Inc May 05, 2026, 11:00 ET Data supports sustained weight loss across diverse populations NEW YORK, May 5, 2026 /PRNewswire/ -- Calibrate, the first integrated clinical and coaching solution for obesity care, today released its 2026 Results Report which draws on one of the largest real-world datasets in behavior-assisted obesity management: more than 50,000 members drawn from nearly six years of clinical data
The drug, an injectable semaglutide, was first approved by the FDA in 2017
Rimando, A
10.1016/S0955-0674(97)80068-3 49 KellerG
For weight management specifically, the same medicine is sold under the name which is called as Zepbound
Why Trust Marie Claire For more than 30 years, Marie Claire has been an internationally recognized destination for news, fashion, and beauty trends, investigative packages, and more